Kobayashi Pharmaceutical Co's quarterly market cap
declined
from Sep. 2023 (円508,154 Mil) to Dec. 2023 (円504,761 Mil) and
declined
from Dec. 2023 (円504,761 Mil) to Mar. 2024 (円368,498 Mil).
Kobayashi Pharmaceutical Co's annual market cap
declined
from Dec. 2021 (円702,733 Mil) to Dec. 2022 (円686,406 Mil) and
declined
from Dec. 2022 (円686,406 Mil) to Dec. 2023 (円504,761 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kobayashi Pharmaceutical Co's Enterprise Value for Today is 円349,439 Mil.
Kobayashi Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kobayashi Pharmaceutical Co's Market Cap
For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kobayashi Pharmaceutical Co's Market Cap Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Kobayashi Pharmaceutical Co's Market Cap falls into.
Kobayashi Pharmaceutical Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co (TSE:4967) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kobayashi Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Kobayashi Pharmaceutical Co (TSE:4967) Business Description
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4967 has been successfully added to your 